Almeda Ventures Limited Partnership is a venture capital firm specializing in seed, start up, early venture and middle market investments. The firm seeks to invest in health technology with focus on public R&D partnership, medical devices, digital health and bio-convergence; life sciences research and development company. It prefers to invest in Israel, USA and Europe. Almeda Ventures Limited Partnership was founded in 2020 and is based in Tel Aviv, Israel.

Almeda Ventures Limited Partnership

Almeda Ventures is a HealthTech focused public R&D partnership. The company invests globally in medical devices, digital health, and bio-convergence. Almeda Ventures supports portfolio companies with expertise, network connections, and resources to drive success in the medical device and digital health sectors.

Almeda Ventures

Almeda Ventures - 
The Next Generation of HealthTech Investments
Investing in Medical Device, Digital Health and Bio-Convergence

Initial responses to ArtiFascia are exciting!

Great testimonial below!
Dr. Michael Groff has been the first user of ArtiFascia, our dural repair graft, which was launched earlier this year. His words say everything 💡 
ArtiFascia has been used in dozens of surgeries successfully, showing exceptional versatility of applications and excellent clinical results.
#neurosurgery #artifascia
https://lnkd.in/dtCWXiEV

Our CEO, Sharon Ravid, was recently featured in an insightful interview with TheMarker, hosted by Gadi Sukenik.
Sharon discussed the innovation behind our product, in2, and how it uses EMS technology to manage Premature Ejaculation.

This interview sheds light on our commitment to advancing sexual health and providing solutions that help couples lead fulfilling intimate lives.

We are dedicated to normalizing conversations around sexual health and addressing intimate issues between couples openly and transparently.

Watch the full video interview on The Marker. 

#TheMarker #Interview #VirilityMedical #in2 #SexualHealth #Innovation #PrematureEjaculation #EMS #MedicalDevice

What a great auidence! thank you for inviting me 🫠

#WCB2024 thank you for everyone to attended our breakfast symposium this morning. Stop by booth #10 to schedule your live virtual case observation. #prostatecancer #rectalspacer #gamechanger

The AXIUS articulating needle driver allows surgeons to precisely follow the needle’s curve through dense fibrous tissue, such as Cooper’s ligament, as well as thin delicate tissue, like peritoneum. 

Accurate needle placement and the ability to drive the needle both towards and away from yourself helps to simplify the challenging suturing in TAPP inguinal hernia repair.

#hernia #herniasurgery #advancedlaparoscopy #innovation #medicaldevices #surgery #minimallyinvasivesurgery #roboticsurgery

לומן, חברת פרוטפוליו של אלמדה. קריאה נעימה

Well done and good luck to Sensi.AI and its amazing team for an impressive closing of its B round!

Almeda Ventures (#LSIEurope24 Investor) is a venture capital firm focused on investments in early-stage medical technology and digital health startups.

Almeda Ventures takes a hands-on approach to its investments, often working closely with its portfolio companies to provide strategic guidance, operational support, and access to a robust network of industry experts and resources. The firm seeks to add value beyond capital by leveraging its deep industry expertise and connections.

They specifically invest in three key areas:
• Medical devices
• Digital health
• Bio-convergence

Almeda is based in Israel and invests globally. Their portfolio includes companies like:
• FlexDex Surgical (James Geiger)
• Nurami Medical (#LSIAlumni - Nora Nseir)
• in2 By Virility Medical (Sharon Ravid)
• among others

We’re thrilled to welcome Dr. Irit Yaniv, Founding Partner and CEO at Almeda Ventures to LSI Europe ‘24 this September 16-20th in Sintra, Portugal.

Want to see what other investors are joining us at LSI Europe ‘24? Head over to our website to see a preview.

	Dec '20	Dec '21	Dec '22	Dec '23
net income	-1.52M -	161.37K 110.65%	-2.25M 1,494.53%	-1.58M 29.70%
depreciation and amortization		198.61K -	270.75K 36.32%	78K 71.19%
deferred income tax		-83.79K -	-63.29K 24.46%
stock based compensation	88.16K -	105.51K 19.68%	56.26K 46.68%	5K 91.11%
change in working capital		-21.72K -	7.03K 132.37%	84K 1,094.47%
accounts receivables		-21.72K -	7.03K 132.37%	-5K 171.10%
inventory
accounts payables
other working capital				89K -
other non cash items	462.83K -	-4.35M 1,039.38%	-3.15M 27.54%	288K 109.14%
net cash provided by operating activities	-964.23K -	-3.99M 313.57%	-5.13M 28.65%	-1.13M 78.03%
investments in property plant and equipment		-6.21K -
acquisitions net
purchases of investments
sales maturities of investments
other investing activites	-35.81M -	-30.82M 13.96%	-7.57M 75.43%	-3.57M 52.83%
net cash used for investing activites	-35.81M -	-30.82M 13.94%	-7.57M 75.44%	-3.57M 52.83%
debt repayment		-204.82K -	-263.71K 28.76%	-70K 73.46%
common stock issued
common stock repurchased
dividends paid
other financing activites	105.99M -	25.78M 75.68%	471.17K 98.17%	-3K 100.64%
net cash used provided by financing activities	105.99M -	25.57M 75.87%	207.46K 99.19%	-73K 135.19%
effect of forex changes on cash		-127.23K -	-207.46K 63.05%	-27K 86.99%
net change in cash	69.21M -	-9.36M 113.53%	-8.76M 6.44%	-4.80M 45.23%
cash at beginning of period		38.98M -	29.62M 24.02%	5.93M 79.97%
cash at end of period	69.21M -	29.62M 57.21%	20.86M 29.58%	1.13M 94.56%
operating cash flow	-964.23K -	-3.99M 313.57%	-5.13M 28.65%	-1.13M 78.03%
capital expenditure		-6.21K -
free cash flow	-964.23K -	-3.99M 314.21%	-5.13M 28.45%	-1.13M 78.03%

AMDA

COM:ALMEDAVENTURES

Almeda Ventures

Last Close

159.50

25/11 08:15

Market Cap

22.27M

Beta: -

Volume Today

100

Avg: -

Preview